First-in-Human Study on Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Doses of HEC88473, a Novel Dual GLP-1 and FGF21 Receptor Agonist in Healthy and Obese Chinese Subjects.

HEC88473 - HEC Pharm

http://www.ncbi.nlm.nih.gov/pubmed/40175670

Can Xie; Hong Chen; Hong Zhang; Jiangyu Yan; Jing Li; Lingfeng Guo; Qianqian Li; Yanhua Ding

Apr 3, 2025